News

Video

Why Relationships are Key When Caring For Patients With MPNs

Fact checked by:

Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.

For patients living with myeloproliferative neoplasms (MPNs), building lasting relationships with the care team can bring strength, comfort and clarity during a challenging journey, according to Dr. Kathryn Johnson, a clinical program manager at The Derald H. Ruttenberg Treatment Center at The Tisch Cancer Institute, part of The Mount Sinai Hospital in New York City.

Known for her deep empathy, Johnson supports not only her patients but also their care teams, ensuring that questions are answered and that treatment plans feel right for everyone involved.

Johnson explains how trust and long-term rapport are central to caring for patients with MPNs. Because these chronic conditions require ongoing treatment, Johnson says, patients and providers have the chance to build deep relationships over time.

She encourages patients to speak up about symptoms and goals, noting that MPNs often manifest differently from person to person. She also emphasizes the importance of bringing a loved one to appointments, both for emotional support and to help patients feel more confident navigating care.

Transcript:

CURE: How do you approach building trust and rapport with your patients with MPN, especially those undergoing treatments, and how can patients lean into their care team and develop that rapport and trust so they feel open to discuss whatever it may be?

Johnson: I think MPNs are chronic disorders, which means that we actually get to establish really lovely long-term relationships with our patients. I have patients that I've seen over the last five years once or twice a month, which is more often than I even get to see my own family in Virginia. So, I think making sure, again, that we're building those long-term relationships with a good foundation of trust by getting to know the patients on a deeper level is really important.

[Patients should] speak up, especially with MPNs, as they do all manifest differently. There are things that we know that people have in common, but they're going to present differently for every person. And I think that there's a lot that people learn to grow with that they don't always realize is impacting them. So, taking a good look at who they are and what their goals are is going to be helpful to managing their care and making sure that they're vocalizing things that aren't sitting right.

[It is also important] that you always encourage [companionship]. Bring a buddy, bring a sister, bring a parent, bring a spouse, bring an adult child. The people who love you and support you and want to help you manage what you're going through.

Transcript has been edited for clarity and conciseness.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.
Related Content